Yield10 Bioscience announced that it has agreed to sell $3.0M of its shares of common stock in a registered direct offering and warrants in a concurrent private placement with investors including a certain institutional investor and an existing investor. Under the terms of the securities purchase agreement, Yield10 has agreed to sell 1,006,710 shares of common stock. The company has also agreed to issue unregistered warrants to purchase 1,006,710 shares of common stock. The combined effective offering price for one share of common stock and accompanying warrant is $2.98. The registered direct offering is expected to close on or about May 5. Maxim Group is acting as sole placement agent for the offering.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on YTEN:
- Yield10 Bioscience to Announce First Quarter 2023 Financial Results and Host a Conference Call on Wednesday, May 10, 2023
- Yield10 Bioscience Announces Pricing of $3.0 Million Registered Direct Offering and Concurrent Private Placement
- Yield10 Bioscience and Marathon Petroleum Corporation Sign LOI for Potential Investment and Offtake Agreement for Camelina Feedstock Oil for Renewable Fuels
- Yield10, Marathon Petroleum sign LOI for potential investment, offtake agreement
- Yield10 Bioscience Announces Fourth Quarter and Full Year 2022 Financial Results